Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Fiona Thomson is a Senior Director of Neuroscience at AstraZeneca.
Dr Threapleton is a specialty registrar in Clinical Pharmacology and Therapeutics and General Internal Medicine at St George's Hospital in London.
David Thwaites is Professor of Epithelial Physiology in the Newcastle University Biosciences Institute within the Faculty of Medical Sciences.
John Traynor is the Edward F Domino Research Professor and Associate Chair for Research in the Department of Pharmacology, University of Michigan Medical School.
Del Trezise is an industrial pharmacologist and biotechnology specialist with over 25 years of experience in applied drug discovery and analytical tools.
Chris R Triggle, PhD, FBPhS joined Weill Cornell Medicine - Qatar in 2007 as Professor of Pharmacology and was the Assistant Dean Admissions 2009-2014.
David Trist joined the BPS in 1975 and became a Fellow in 2014.
Steve Tucker is a Professor of Pharmacology Education at the University of Aberdeen, where he heads the undergraduate Pharmacology programmes and the post-graduate Clinical Pharmacology/Drug Discovery programmes.
Dr Richard M Turner MA, MB BChir, PhD, MRCP (UK) is a director in GSK whose team undertakes novel translational and pharmacogenetic research to support drug development.